NETWORK PHARMACOLOGY, APOPTOSIS, AND CELL CYCLE INHIBITION OF SESQUITERPENE COMPOUNDS FROM QUSTHUL HINDI ROOT EXTRACT (SAUSSUREA LAPPA) IN BREAST CANCER: AN IN SILICO AND IN VITRO APPROACH

ROIHATUL MUTIAH; SUKARDIMAN; ALVI MILLIANA; ERMIN RAHMAWATI; AVIN AINUR FITRIANINGSIH; YUYUN YUENIWATI

doi:10.22159/ijap.2023v15i6.48798

Authors

ROIHATUL MUTIAH Department of Pharmacy, Faculty of Medicine and Health Sciences, UIN Maulana Malik Ibrahim Malang, East Java, Indonesia https://orcid.org/0000-0002-8196-9029
SUKARDIMAN Department Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Universitas Airlangga, Indonesia
ALVI MILLIANA Department of Medicine, Faculty of Medicine and Health Sciences, UIN Maulana Malik Ibrahim Malang, East Java, Indonesia
ERMIN RAHMAWATI Department of Medicine, Faculty of Medicine and Health Sciences, UIN Maulana Malik Ibrahim Malang, East Java, Indonesia https://orcid.org/0000-0003-1045-7066
AVIN AINUR FITRIANINGSIH Department of Medicine, Faculty of Medicine and Health Sciences, UIN Maulana Malik Ibrahim Malang, East Java, Indonesia https://orcid.org/0000-0002-3571-114X
YUYUN YUENIWATI Department of Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia, East Java, Indonesia https://orcid.org/0000-0001-9932-2015

DOI:

https://doi.org/10.22159/ijap.2023v15i6.48798

Keywords:

Qusthul Hindi, Network pharmacology, HER2, T47D, Apoptosis, Cell cycle

Abstract

Objective: The objective of this study was to evaluate the potential and mechanisms of compounds in Qusthul Hindi extract in inhibiting proliferation, cell cycle, and inducing cell death in breast cancer through a network pharmacology approach, in silico validation, and in vitro experiments.

Methods: This research employed a literature review approach to identify anti-cancer compounds and utilized a network pharmacology approach to predict the mechanisms of action of the compounds. Insilico docking was performed on the HER2 receptor (PDB: 3PP0) using Molegro Virtual Docker 6.0. Furthermore, the MTT method was used to evaluate the cytotoxic effects of Qusthul Hindi extract on T47D cells, and Flow cytometry was employed to determine the effects of the extract on apoptosis and cell cycle.

Results: The network pharmacology analysis revealed that Qusthul Hindi interacted with 66 genes related to breast cancer. Pathway analysis showed a close association between Qusthul Hindi and important signaling pathways such as P53, MAPK, PI3K-Akt, and the cell cycle. Molecular docking results showed better affinity of Saussureamine B and C towards the HER2 receptor compared to trastuzumab. In vitro cytotoxicity assays demonstrated the potential activity of Qusthul Hindi extract against T47D cells (IC50: 32.81 µg/ml). Qusthul Hindi also effectively induced apoptosis in breast cancer cells with a high percentage (85.3%), and inhibited the cell cycle by reducing the G2-M and S phases. Statistical analysis revealed significant differences between the Qusthul Hindi treatment group and the control group in terms of apoptotic cell count (p<0.001).

Conclusion: These findings suggest that Qusthul Hindi has potential for development as an anti-cancer agent through the inhibition of proliferation, induction of apoptosis, and cell cycle inhibition in breast cancer.

Downloads

Download data is not yet available.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660, PMID 33538338.

Kayl AE, Meyers CA. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol. 2006;18(1):24-8. doi: 10.1097/01.gco.0000192996.20040.24, PMID 16493256.

Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682-90. doi: 10.1038/nchembio.118, PMID 18936753.

Fang J, Wang L, Wu T, Yang C, Gao L, Cai H. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment. J Ethnopharmacol. 2017;196:281-92. doi: 10.1016/j.jep.2016.11.034, PMID 27888133.

Zhang W, Chen Y, Jiang H, Yang J, Wang Q, Du Y. Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta. 2020;211:120710. doi: 10.1016/j.talanta.2020.120710, PMID 32070601.

Boezio B, Audouze K, Ducrot P, Taboureau O. Network-based approaches in pharmacology. Mol Inform. 2017;36(10):1700048. doi: 10.1002/minf.201700048, PMID 28692140.

Al-Jauziya IIQ. Healing with the medicine of the prophet (PBUH). Darussalam; 1999.

El-Far A, Shaheen H, Alsenosy A, El-Sayed Y, Al Jaouni S, Mousa S. Costus speciosus: traditional uses, phytochemistry, and therapeutic potentials. Phcog Rev. 2018;12(23). doi: 10.4103/phrev.phrev_29_17.

Hassan R, Masoodi MH. Saussurea lappa: a comprehensive review on its pharmacological activity and phytochemistry. Curr Tradit Med. 2020;6(1):13-23. doi: 10.2174/2215083805666190626144909.

Abdallah EM, Qureshi KA, Ali AMH, Elhassan GO. Evaluation of some biological properties of Saussurea costus crude root extract. Biosci Biotech Res Comm. 2017;10(4):601-11. doi: 10.21786/bbrc/10.4/2.

Mutiah R, Listiyana A, Indradmojo C, Griana TP, Dwi HH, Atmaja RRD. Induction of apoptosis and phase-cell cycle inhibition of G0-G1, S, G2-M of T47D breast cancer cells on treatment with ethyl acetate fraction of jackfruit parasite leaves (Macrosolen cochinensis). J Appl Pharm Sci. 2017;7(10):138-43.

Liu X, Wu J, Zhang D, Wang K, Duan X, Zhang X. A network pharmacology approach to uncover the multiple mechanisms of Hedyotis diffusa willd. on colorectal cancer. Evid Based Complement Alternat Med. 2018;2018:6517034. doi: 10.1155/2018/6517034, PMID 29619072.

Jiang L, Lu J, Qin Y, Jiang W, Wang Y. Antitumor effect of guava leaves on lung cancer: a network pharmacology study. Arab J Chem. 2020;13(11):7773-97. doi: 10.1016/j.arabjc.2020.09.010.

Zhou Z, Chen B, Chen S, Lin M, Chen Y, Jin S. Applications of network pharmacology in traditional Chinese medicine research. Evid Based Complement Alternat Med. 2020;2020:1646905. doi: 10.1155/2020/1646905, PMID 32148533.

Mutiah R, Hariz MF, Indrawijaya YYA, Ma’arif B. In silico prediction of isoliquiritigenin and oxyresveratrol compounds to BCL-2 dan VEGF-2 receptors. Indones J Cancer Chemoprevent. 2019;10(2):51-9. doi: 10.14499/indonesianjcanchemoprev10iss2pp51-59.

Mutiah R, Sukardiman WA, Widyawaruyanti A. Cytotoxic effect of crude extract and fraction from calotropis gigantea Leaves O. Human C. Cancer Widr cell lines. Int J Pharm Pharm Sci. 2017;9(1). doi: 10.22159/ijpps.2017v9i1.9022.

Amalina ND, Salsabila IA, Zulfin UM, Jenie RI, Meiyanto E. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells. J Egypt Natl Canc Inst. 2023;35(1):6. doi: 10.1186/s43046-023-00166-3, PMID 36967442.

Hastuti HEA, Adisusilo MRP, Ashar YA, Meiyanto E, Jenie RI. Revealing the potential of compounds in sappan wood as cervical cancer metastasis chemopreventive agent with MMP9 target. Indones J Cancer Chemoprevent. 2022;13(1):22-32. doi: 10.14499/indonesianjcanchemoprev13iss1pp22-32.

Mutiah R, Minggarwati TS, Kristanti RA, Susanti E. Compound identification and anticancer activity of ethyl acetate fraction from bawang sabrang (Eleutherine palmifolia (L.) Merr.) on HeLa cervical cancer cell line. Indones J Cancer Chemoprevent. 2019;10(3):131-9. doi: 10.14499/indonesianjcanchemoprev10iss3pp131-139.

Sun H, Yin M, Hao D, Shen Y. Anti-cancer activity of catechin against A549 lung carcinoma cells by induction of cyclin kinase inhibitor p21 and suppression of cyclin E1 and P–AKT. Appl Sci. 2020;10(6):2065. doi: 10.3390/app10062065.

Ansari S, Maaz M, Ahmad I, Hasan SK, Bhat SA, Naqui SK. Quality control, HPTLC analysis, antioxidant and antimicrobial activity of hydroalcoholic extract of roots of qust (Saussurea lappa, C.B Clarke). Drug Metab Pers Ther. 2020:20200159. doi: 10.1515/dmdi-2020-0159, PMID 33780194.

Sen S, Chakraborty R. editors. Herbal medicine in India: indigenous knowledge, practice, innovation and its value. Springer; 2020. doi: 10.1007/978-981-13-7248-3.

Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers. 2019;11(10):1618. doi: 10.3390/cancers11101618, PMID 31652660.

Zhu C, Qi X, Chen Y, Sun B, Dai Y, Gu Y. PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol. 2011;137(11):1587-94. doi: 10.1007/s00432-011-1049-2, PMID 21904903.

Issinger OG, Guerra B. Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling. Biomed Pharmacother. 2021;139:111650. doi: 10.1016/j.biopha.2021.111650, PMID 33945911.

Paplomata E, O’Regan R. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Oncol. 2014;6(4):154-66. doi: 10.1177/1758834014530023, PMID 25057302.

Yang L, Hou Y, Yuan J, Tang S, Zhang H, Zhu Q. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Oncotarget. 2015;6(28):25755-69. doi: 10.18632/oncotarget.4697, PMID 26342198.

Issaeva N. p53 signaling in cancers. Cancers. 2019;11(3):332. doi: 10.3390/cancers11030332, PMID 30857153.

Gasco M, Shami S, Crook T. The p53 pathway in breast cancer. Breast Cancer Res. 2002;4(2):70-6. doi: 10.1186/bcr426, PMID 11879567.

Lee SJ, Moon GS, Jung KH, Kim WJ, Moon SK. C-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells. Food Chem Toxicol. 2010;48(1):277-83. doi: 10.1016/j.fct.2009.09.042, PMID 19833164.

Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem. 2006;97(2):261-74. doi: 10.1002/jcb.20690, PMID 16267837.

Zainuddin NASN, Zakaria Y, Sula MD. Dendrophthoe pentandra induced apoptosis and cell cycle arrest at G1/S in human breast adenocarcinoma cells, MCF-7 via Upregulation of p53. J App Pharm Sci. 2018;8(9):130-41. doi: 10.7324/JAPS.2018.8919.

Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology. 2001;61Suppl 2:1-13. doi: 10.1159/000055396, PMID 11694782.

Loibl S, Gianni L. LHER2-positive breast cancer. Lancet. 2017;389(10087):2415-29. doi: 10.1016/S0140-6736(16)32417-5, PMID 27939064.

Zeng L, Yang K. Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach. J Ethnopharmacol. 2017;199:68-85. doi: 10.1016/j.jep.2017.01.045, PMID 28130113.

Baselga J, Perez EA, Pienkowski T, Bell R. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. Oncologist. 2006;11Suppl 1:4-12. doi: 10.1634/theoncologist.11-90001-4, PMID 16971734.

Kroll DJ. Natural compounds in cancer therapy: promising nontoxic antitumor agents from plants and other natural sources John Boik (University of Texas). Oregon Medical Press, Princeton. J Nat Prod. 2001;64(12).521. doi: 10.1021/np000765k.

Demidenko ZN, Kalurupalle S, Hanko C, Lim CU, Broude E, Blagosklonny MV. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub-G1 DNA content mediated by prolonged mitosis. Oncogene. 2008;27(32):4402-10. doi: 10.1038/onc.2008.82, PMID 18469851.

Shu CH, Yang WK, Shih YL, Kuo ML, Huang TS. Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis. Apoptosis. 1997;2(5):463-70. doi: 10.1023/a:1026422111457, PMID 14646529.

Preethi S, Kumar H, Rawal VB, Ajmeer R, Jain V. Overview of mitoxantrone-a potential candidate for the treatment of breast cancer. Int J Appl Pharm. 2022;14:10-22.